Search the Site

Search Results for: bad medicne

Episode 417

Reasons to Be Cheerful (Replay)

Humans have a built-in “negativity bias,” which means we give bad news much more power than good. Would the Covid-19 crisis be an opportune time to reverse this tendency?

Episode 417

Reasons to Be Cheerful

Humans have a built-in “negativity bias,” which means we give bad news much more power than good. Would the Covid-19 crisis be an opportune time to reverse this tendency?

Episode 53

What’s the Secret to Making a Great Prediction?

Also: How do you recover from a bad day?…

Episode 495

Why Are There So Many Bad Bosses? (Replay)

People who are good at their jobs routinely get promoted into bigger jobs they’re bad at. We explain why firms keep producing incompetent managers — and why that’s unlikely to…

Episode 353

How to Optimize Your Apology

You said, “I’m sorry,” but somehow you haven’t been forgiven. Why? Because you’re doing it wrong! A report from the front lines of apology science.

Episode 70

Why Are There Still So Few Female Surgeons?

Success and failure are hard to measure in medicine. Bapu looks at how surgeons are judged after a bad outcome — and whether men and women are treated the same….

Episode 495

Why Are There So Many Bad Bosses? (Update)

People who are good at their jobs routinely get promoted into bigger jobs they’re bad at. We explain why firms keep producing incompetent managers — and why that’s unlikely to…

Episode 495

Why Are There So Many Bad Bosses?

People who are good at their jobs routinely get promoted into bigger jobs they’re bad at. We explain why firms keep producing incompetent managers — and why that’s unlikely to…

Freakonomics Radio Live: “Where Does Fear Live in the Brain?”

Our co-host is comedian Christian Finnegan, and we learn: the difference between danger and fear; the role of clouds in climate change; and why (and when) politicians are bad at…

Episode 182

Is It Good or Bad to Keep Secrets?

Should you shout your sins from the rooftops? How many skeletons are in the average person’s closet? And what has Angela been hiding?…

Episode 269

Bad Medicine, Part 2: (Drug) Trials and Tribulations (Replay)

How do so many ineffective and even dangerous drugs make it to the market? One reason is that clinical trials are often run on “dream patients” who aren’t representative of…

Episode 56

Why Is Academic Writing So Bad?

Also: what does your perfect day look like?…

Episode 2

The Garbage Can Model of Decision Making

What’s it like to try and police millions of pieces of abusive content every day? Sudhir takes us inside Facebook, as he and his former colleagues recall how hard it…

Episode 477

Why Is U.S. Media So Negative? (Replay)

Breaking news! Sources say American journalism exploits our negativity bias to maximize profits, and social media algorithms add fuel to the fire. Stephen Dubner investigates….

Episode 477

Why Is U.S. Media So Negative?

Breaking news! Sources say American journalism exploits our negativity bias to maximize profits, and social media algorithms add fuel to the fire. Stephen Dubner investigates. (This is part of the…

Episode 142

Is Pride the Worst Sin?

Is pride an emotion? Where’s the line between self-esteem and hubris? And what does Stephen have against peacocks? Take the Seven Deadly Sins survey: freakonomics.com/nsq-sins/…

Episode 82

Which Is More Powerful: Reward or Punishment?

How is “negative reinforcement” different from punishment? Could positive reinforcement encourage prosocial behavior on a national scale? And what’s the deal with Taiwan’s dog-poop lottery?…

Episode 269

Bad Medicine, Part 2: (Drug) Trials and Tribulations

How do so many ineffective and even dangerous drugs make it to market? One reason is that clinical trials are often run on “dream patients” who aren’t representative of a…

Episode 19

Is There Such a Thing as Good Estrangement?

Also: How do you know if you have a “bad personality?”…

Episode 152

Everybody Gossips (and That’s a Good Thing)

The benefits of rumor-mongering.

Episode 270

Bad Medicine, Part 3: Death by Diagnosis (Replay)

By some estimates, medical error is the third-leading cause of death in the U.S. How can that be? And what’s to be done? Our third and final episode in this…

Episode 64

The Days of Wine and Mouses

Do more expensive wines taste better? And: what does one little rodent in a salad say about a restaurant’s future? This is a “mashupdate” of “Do More Expensive Wines Taste…

Episode 199

This Idea Must Die

Every year, Edge.org asks its salon of big thinkers to answer one big question. This year’s question borders on heresy: what scientific idea is ready for retirement?

Episode 151

Is It Okay to Be Average?

Must one always strive for excellence? Is perfectionism a good thing? And can Mike have two bad days in a row?

Episode 544

Ari Emanuel Is Never Indifferent

He turned a small Hollywood talent agency into a massive sports-and-entertainment empire. In a freewheeling conversation, he explains how he did it and why it nearly killed him….

Episode 497

Can the Big Bad Wolf Save Your Life?

Every year, there are more than a million collisions in the U.S. between drivers and deer. The result: hundreds of deaths, thousands of injuries, and billions in damages. Enter the…

Episode 335

Does Doing Good Give You License to Be Bad?

Corporate Social Responsibility programs can attract better job applicants who’ll work for less money. But they also encourage employees to misbehave. Don’t laugh — you too probably engage in “moral…

Episode 327

Extra: Carol Bartz Full Interview

Stephen Dubner’s conversation with the former C.E.O. of Yahoo!, recorded for the Freakonomics Radio series “The Secret Life of a C.E.O.”…

Episode 94

The Price of Doing Business with John List

From baseball card conventions to Walmart, John List has always used field experiments to say revolutionary things about economics. He explains the value of an apology, why scaling shouldn’t be…

Episode 573

Can Academic Fraud Be Stopped?

Probably not — the incentives are too strong. Scholarly publishing is a $28 billion global industry, with misconduct at every level. But a few reformers are gaining ground. (Part two…